Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7
- 1 November 2003
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 33 (11) , 1073-1083
- https://doi.org/10.1080/00498250310001609129
Abstract
1. Almokalant, a class III antiarrythmic drug, is metabolized to form isomeric glucuronides identified in human urine. Synthesis of the total glucuronide was studied in human liver and kidney microsomes. Recombinant UDP-glucuronosyltransferases (UGTs) were screened for activity and kinetic analysis was performed to identify the isoform(s) responsible for the formation of almokalant glucuronide in man. 2. From a panel of recombinant isoforms used, both UGT1A9 and 2B7 catalysed the glucuronidation of almokalant. The Km values in both instances were similar with 1.06 mM for the 1A9 and 0.97 mM for the 2B7. Vmax for 1A9 was fourfold higher than that measured for UGT2B7, 92 compared with 21 pmol min−1 mg−1, respectively, but UGT1A9 was expressed at approximately twofold higher level than the UGT2B7 in the recombinant cell lines. Therefore, the contribution of UGT2B7 to almokalant glucuronidation could be as significant as that of UGT1A9 in man. 3. Liver and kidney microsomes displayed similar Km values to the cloned expressed UGTs, with the liver and kidney microsomes at 1.68 and 1.06 mM almost identical to the 1A9. 4. The results suggest a significant role for UGT1A9 and 2B7 in the catalysis of almokalant glucuronidation.Keywords
This publication has 9 references indexed in Scilit:
- Genetic Variation of Human UDP-GlucuronosyltransferaseAmerican Journal of PharmacoGenomics, 2003
- Drug Glucuronidation by Human Renal UDP-Glucuronosyltransferases 11The nomenclature used in this manuscript is based on published recommendations and is to be defined by the position of the variable exon within the gene complex [45]. The position of the specific isoform formerly known as HlugP4 or UGT1∗02 has yet to be resolved. As such, the nomenclature for this isoform will be stated as UGT1A8/9.Biochemical Pharmacology, 1998
- A Universal Radiochemical High-Performance Liquid Chromatographic Assay for the Determination of UDP-Glucuronosyltransferase ActivityAnalytical Biochemistry, 1998
- Managing the drug discovery/development interfaceDrug Discovery Today, 1997
- The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugsBiochemical Pharmacology, 1993
- Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivativesBiochemistry, 1992
- Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).British Journal of Clinical Pharmacology, 1988
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970